Intellipharmaceutics International Inc. (IPCI)

[wimuskyfisherman]

Fabius- I think Odidi is arrogant to the fact that he has no concept on how to run the company. He is delusional... For some reason he thinks his patents and his pipeline will be worth something someday. Unfortunately he has no clue on how to determine what products there is a market for and what products there is not a market for. He now admits the ANDA pipleline was the wring direction as the market for generics changed. However he did not adapt quickly enough to the change in markets. Now he says the company is focusing on NDAs. Namely Rexista and Regabatin. We all know that Regabatin is on the shelf and collecting dust. How can Odidi not see he is failing in the NDA realm as well. Take a look at this interview from February 2017:

https://www.midasletter.com/2017/02/intellipharmaceutics-ceo-dr-issa-odidi-preventing-overdose-death-oxycodone-fentanyl/

Odidi toots his own horn on three things:

1. Rexista
2. All the applications for PODRAS. Here is an exact quote And then there are several combination products that are coming for opiates, these are based on our PODRAS technology, the abuse deterrent technology and the overdose technology. And then we are looking at several other once-a-day products with regards to hydromorphone,oxymorphone and hydrocodone. And like I said earlier, there are several more we haven’t made public, and therefore I won’t be able to talk about them.
3. Regabatin

But since this interview, we have heard absolutely nothing on items 2 and 3. Odidi is a man of A LOT OF TALK BUT VERY LITTLE ACTION.